Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study
Mylène Duivon(Inserm), Florence Joly(Centre François Baclesse), Antonio Di Meglio(Inserm), Florence Lerebours(Institut Curie), Justine Lequesne(Centre Henri Becquerel), Christelle Lévy(Centre François Baclesse), Dominique Delmas(Inserm), Emilie Thomas(Université Claude Bernard Lyon 1), Hélène Castel(Centre Hospitalier de l’Université de Montréal), Olivier Rigal(Centre Henri Becquerel), Kathleen Van Dyk(UCLA Jonsson Comprehensive Cancer Center), François Christy(Inserm), Inês Vaz-Luís(Institut Gustave Roussy), Patricia A. Ganz(University of California, Los Angeles), Catherine Gaudin(UniCancer Group), Sandrine Boyault(Wellcome Sanger Institute), Marie Lange(Inserm), Chayma Bousrih(Institut Gustave Roussy)
Cited by 3
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The Life History of 21 Breast Cancers
|Cell|2012|1.5k